Literature DB >> 9201221

Attenuation of B5R mutants of rabbitpox virus in vivo is related to impaired growth and not an enhanced host inflammatory response.

R J Stern1, J P Thompson, R W Moyer.   

Abstract

The rabbitpox virus (RPV) B5R protein, synthesized late in infection, is found as a 45-kDa membrane-associated protein of the envelope of infectious extracellular enveloped virus (EEV) and as a 38-kDa protein secreted from the cell by a process independent of morphogenesis. The protein is not found associated with intracellular mature virus (IMV). Deletion of the gene attenuates the virus (RPV delta B5R) in animals (mice and rabbits), has relatively little effect on formation of IMV, prevents EEV formation in some but not all cells, and leads to a reduced host range. Analysis of the sequence of the protein suggests relatedness to factor H of the complement cascade. Collectively, these observations suggest that attenuation of the virus in vivo could be linked to an inhibition of the inflammatory response, a deficiency in growth, or both. In this report we have analyzed the behavior of RPV delta B5R in infected mice and rabbits and conclude that attenuation of the mutant virus likely results from simple failure to grow within the infected animal and that the inflammatory response probably contributes little to the observed attenuation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201221     DOI: 10.1006/viro.1997.8556

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Protective properties of vaccinia virus-based vaccines: skin scarification promotes a nonspecific immune response that protects against orthopoxvirus disease.

Authors:  Amanda D Rice; Mathew M Adams; Scott F Lindsey; Daniele M Swetnam; Brandi R Manning; Andrew J Smith; Andrew M Burrage; Greg Wallace; Amy L MacNeill; Richard W Moyer
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

2.  Genetic characterization and phylogenetic analysis of host-range genes of Camelpox virus isolates from India.

Authors:  B C Bera; S Barua; K Shanmugasundaram; T Anand; T Riyesh; R K Vaid; N Virmani; S Kundu; N K Yadav; P Malik; R K Singh
Journal:  Virusdisease       Date:  2015-07-17

3.  Mutational analysis of vaccinia virus E3 protein: the biological functions do not correlate with its biochemical capacity to bind double-stranded RNA.

Authors:  Kevin J Dueck; YuanShen Sandy Hu; Peter Chen; Yvon Deschambault; Jocelyn Lee; Jessie Varga; Jingxin Cao
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  Roles of vaccinia virus genes E3L and K3L and host genes PKR and RNase L during intratracheal infection of C57BL/6 mice.

Authors:  Amanda D Rice; Peter C Turner; Jennifer E Embury; Lyle L Moldawer; Henry V Baker; Richard W Moyer
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

5.  Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.

Authors:  E Herrera; M M Lorenzo; R Blasco; S N Isaacs
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  A survey of host range genes in poxvirus genomes.

Authors:  Kirsten A Bratke; Aoife McLysaght; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2012-12-23       Impact factor: 3.342

Review 7.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342

Review 8.  Poxvirus homologues of cellular genes.

Authors:  J J Bugert; G Darai
Journal:  Virus Genes       Date:  2000       Impact factor: 2.198

9.  Development of ST-246® for Treatment of Poxvirus Infections.

Authors:  Robert Jordan; Janet M Leeds; Shanthakumar Tyavanagimatt; Dennis E Hruby
Journal:  Viruses       Date:  2010-11-03       Impact factor: 5.818

Review 10.  Extracellular Virions: The Advance Guard of Poxvirus Infections.

Authors:  David J Pickup
Journal:  PLoS Pathog       Date:  2015-07-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.